Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 479-487

  Overk, Cassia R ^a   Lu, Pei Yi ^b   Wang, Yue Ting ^b   Choi, Jaewoo ^b   Shaw, James W ^b   Thatcher, Gregory R ^b   Mufson, Elliott J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFICACY; ESTROGEN RELEASE; FEMALE; GONADECTOMY; HIPPOCAMPAL CA1 REGION; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AROMATASE INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; MALE; MICE; MICE, TRANSGENIC; NEURONS; NITRILES; ORCHIECTOMY; OVARIECTOMY; PLAQUE, AMYLOID; TRIAZOLES;

EID: 81955167454     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.08.035     Document Type: Article

References (50)

1. Andersen K., et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999, 53:1992-1997.
2. Barrie S.E., et al. Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase). J. Steroid Biochem. Mol. Biol. 1994, 50:267-273.
3. Bender C.M., et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007, 14:995-998.
4. Boyar R., et al. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. New Engl. J. Med. 1972, 287:582-586.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
6. Braak H., et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
7. Carroll J.C., et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27:13357-13365.
8. Carroll J.C., et al. Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology 2010, 151:2713-2722.
9. Castellon S.A., et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J. Clin. Exp. Neuropsychol. 2004, 26:955-969.
10. Gao S., et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry. 1998, 55:809-815.
11. Gould E., et al. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10:1286-1291.
12. Goyal S., et al. Excellent response to letrozole in brain metastases from breast cancer. Acta Neurochir. 2008, 150:613-614.
13. Grodin J.M., et al. Source of estrogen production in postmenopausal women. J. Clin. Endocrinol. Metab. 1973, 36:207-214.
14. Gundersen H.J., et al. The efficiency of systematic sampling in stereology-reconsidered. J. Microsc. 1999, 193:199-211.
15. Hof P.R., et al. Human orbitofrontal cortex: cytoarchitecture and quantitative immunohistochemical parcellation. J. Comp. Neurol. 1995, 359:48-68.
16. Hogervorst E., et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuro. Endocrinol. Lett. 2001, 22:163-168.
17. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6:65-70.
18. Howell A. The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer. Rev. Recent Clin. Trials. 2006, 1:207-215.
19. Hy L.X., Keller D.M. Prevalence of AD among whites: a summary by levels of severity. Neurology 2000, 55:198-204.
20. Ishunina T.A., et al. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol. Aging 2005, 26:173-194.
21. Jaffar S., et al. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Exp. Neurol. 2001, 170:227-243.
22. Jenkins V.A., et al. Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol 2008, 9:953-961.
23. Kil K.E., et al. Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug. Nucl. Med. Biol. 2009, 36:215-223.
24. Ma S.Y., et al. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. J. Comp. Neurol. 1999, 409:25-37.
25. Meyer R.P., et al. Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J. Neurochem. 2006, 96:460-472.
26. Morley J.E. Androgens and aging. Maturitas 2001, 38:61-71.
27. Mufson E.J., et al. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 1997, 146:91-103.
28. Mukai H., et al. Modulation of synaptic plasticity by brain estrogen in the hippocampus. Biochim. Biophys. Acta. 2010, 1800:1030-1044.
29. Nelson S.R., et al. Use of specific gravity in the measurement of cerebral edema. J. Appl. Physiol. 1971, 30:268-271.
30. Oddo S., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
31. Oh K.J., et al. Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis. Int. J. Alzheimers Dis. 2010.
32. Overk C.R., et al. Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2009, 35:415-425.
33. Overk C.R., et al. A novel approach for long-term oral drug administration in animal research. J. Neurosci. Methods. 2011, 195:194-199.
34. Paxinos G., Franklin K. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, London.
35. Pearse G., et al. Urinary retention and cystitis associated with subcutaneous estradiol pellets in female nude mice. Toxicol. Pathol. 2009, 37:227-234.
36. Perez S.E., et al. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice. J. Neurosci. 2005, 25:10220-10229.
37. Pike C.J., et al. Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 2009, 30:239-258.
38. Plourde P.V., et al. Arimidex: a potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res. Treat. 1994, 30:103-111.
39. Rosario E.R., et al. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J. Neurosci. 2006, 26:13384-13389.
40. Rosario E.R., et al. Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res. 2010, 1359:281-290.
41. Rousseeuw P., Leroy A. Robust Regression and Outlier Detection 1987, Wiley, New York.
42. Rousseeuw P., Yohai V. Robust regression by means of S-estimators. Nonlinear Time Ser. Anal. Lect. Notes Stat. 1984, 26:256-272.
43. unlisted Canadian study of health and aging: study methods and prevalence of dementia. Can. Med. Assoc. J. 1994, 150:899-913.
44. Weiland N.G., et al. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J. Comp. Neurol. 1997, 388:603-612.
45. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12:2549-2554.
46. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 1993, 336:293-306.
47. Woolley C.S., et al. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J. Neurosci. 1990, 10:4035-4039.
48. Woolley C.S., et al. Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J. Comp. Neurol. 1996, 373:108-117.
49. Yu J., et al. An ultraperformance liquid chromatography-tandem mass spectrometry method for determination of anastrozole in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr. 2011, 25:511-516.
50. Yue X., et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19198-19203.